2023
Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia’s invasion of Ukraine in five major cities in Ukraine
Mazhnaya A, Meteliuk A, Pykalo I, Altice F. Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia’s invasion of Ukraine in five major cities in Ukraine. Frontiers In Public Health 2023, 11: 1238188. PMID: 38162610, PMCID: PMC10756895, DOI: 10.3389/fpubh.2023.1238188.Peer-Reviewed Original ResearchConceptsPrivate clinicsOpioid use disorder patientsInvasion of UkraineOpioid use disorderDosage reductionTreatment optionsFull-scale invasion of UkraineHealth system navigationQualitative explorationExperiences of patientsQualitative semi-structured interviewsMOUD treatmentUse disorderPatientsRussia's invasion of UkraineFull-scale invasionDisorder patientsClinicState-funded clinicsSemi-structured interviewsMOUDMOUD deliveryMedication availabilityState-funded facilitiesPatient experiencePsychometric Evaluation and Validation of the HIV Stigma Scale in Spanish Among Men Who Have Sex With Men and Transgender Women
Ranjit Y, Krishnan A, Earnshaw V, Weikum D, Ferro E, Sanchez J, Altice F. Psychometric Evaluation and Validation of the HIV Stigma Scale in Spanish Among Men Who Have Sex With Men and Transgender Women. Stigma And Health 2023, 8: 437-444. PMID: 38434589, PMCID: PMC10906740, DOI: 10.1037/sah0000302.Peer-Reviewed Original ResearchHIV Stigma ScaleTransgender womenStigma ScaleResource-limited settingsGood construct validityHIV clinicHIV stigmaDepressive symptomsMeasures of stigmaHIVInternalized stigmaPsychometric evaluationSociodemographic measuresMenSexMSMSocial supportConstruct validityEmployment statusSpanish versionConfirmatory factor analysisPsychometric propertiesWomenStigmaClinicLeveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees
Nikitin B, Bromberg D, Madden L, Stöver H, Teltzrow R, Altice F. Leveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees. PLOS Global Public Health 2023, 3: e0002168. PMID: 37440470, PMCID: PMC10343058, DOI: 10.1371/journal.pgph.0002168.Peer-Reviewed Original ResearchOpioid use disorderAgonist maintenance therapyMaintenance therapyInjection drug usePrevention of HIVGold standard treatmentRisk of HIVHigh prevalence ratesCare continuityStandard treatmentPrevalence ratesUse disordersImplementation science lensDrug useHarm reductionTreatment modelHIVPatientsClinicTherapyAddiction treatment modelsTreatmentProvidersInvasionInterview participantsDesign, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine
Machavariani E, Bromberg D, Dumchev K, Dvoriak S, Zeziulin O, Morozova O, Esserman D, Pykalo I, Saichuk N, Ivasiy R, Haddad M, Altice F. Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine. Contemporary Clinical Trials 2023, 131: 107248. PMID: 37263492, PMCID: PMC10527419, DOI: 10.1016/j.cct.2023.107248.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyMajor depressive disorderCo-occurring disordersAgonist therapyDepressive disorderSpecialty clinicPsychiatric disordersPatient-level outcomesPrevalent psychiatric disordersCluster-randomized trialPoor health outcomesProvider-level dataMDD treatmentTreatment algorithmExperimental armHigh prevalenceDelivery outcomesHealth outcomesSerial surveysClinicPatientsProject ECHOSubstance useMonthsDisorders
2022
Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial
Pashchenko O, Bromberg D, Dumchev K, LaMonaca K, Pykalo I, Filippovych M, Esserman D, Polonsky M, de Leon S, Morozova O, Dvoriak S, Altice F. Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial. PLOS Global Public Health 2022, 2: e0000344. PMID: 36962514, PMCID: PMC10021202, DOI: 10.1371/journal.pgph.0000344.Peer-Reviewed Original ResearchPrimary care clinicsOpioid use disorderOpioid agonist therapyPrimary careComplete self-reported dataPatient medical record dataMedical record dataComprehensive health outcomesAddiction treatment clinicsAdult PWIDAgonist therapySecondary outcomesParent trialPrimary outcomeRandomized participantsCare clinicsTreatment clinicsIntervention sitesUse disordersHealth outcomesAddiction treatmentRecord dataSelf-reported dataHealth indicatorsClinic
2017
Innovative Program Delivery and Determinants of Frequent Visitation to a Mobile Medical Clinic in an Urban Setting
Gibson BA, Morano JP, Walton MR, Marcus R, Zelenev A, Bruce RD, Altice FL. Innovative Program Delivery and Determinants of Frequent Visitation to a Mobile Medical Clinic in an Urban Setting. Journal Of Health Care For The Poor And Underserved 2017, 28: 643-662. PMID: 28529215, DOI: 10.1353/hpu.2017.0065.Peer-Reviewed Original ResearchConceptsMobile medical clinicMedical clinicsInjection drug useVulnerable populationsHealth careHealth insurance coveragePatient characteristicsContinuous health careAcute careAffordable Care ActDrug useNegative binomial regressionInsurance coverageCare ActCareCertain populationsUtilization patternsBinomial regressionClinicVisitsProgram deliveryUnique clientsNew HavenPopulationSpecific indicators
2014
Correlates of Having Never Been HIV Tested among Entrants to Substance Abuse Treatment Clinics: Empiric Findings from Real-World New England Settings
Chadwick JJ, Andrade LF, Altice FL, Petry NM. Correlates of Having Never Been HIV Tested among Entrants to Substance Abuse Treatment Clinics: Empiric Findings from Real-World New England Settings. Journal Of Psychoactive Drugs 2014, 46: 208-214. PMID: 25052879, PMCID: PMC4780256, DOI: 10.1080/02791072.2014.915363.Peer-Reviewed Original ResearchMeSH KeywordsAdultChi-Square DistributionDrug UsersEmploymentFemaleHealth Knowledge, Attitudes, PracticeHealth StatusHIV InfectionsHumansLogistic ModelsMaleMiddle AgedNew EnglandOdds RatioPatient Acceptance of Health CarePredictive Value of TestsRisk FactorsSerologic TestsSex FactorsSubstance Abuse Treatment CentersSubstance-Related DisordersConceptsSubstance abuse treatment patientsSubstance abuse treatment clinicsSubstance abuse patientsSubstance abuse treatmentHIV testingTreatment patientsMale genderTreatment clinicsAbuse patientsHIVPatientsMedical problemsAbuse treatmentRoutine testingClinicSignificant minorityReal-world evaluationEmpiric findingsTesting strategiesTreatmentTestingAccessibility and utilization patterns of a mobile medical clinic among vulnerable populations
Gibson BA, Ghosh D, Morano JP, Altice FL. Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations. Health & Place 2014, 28: 153-166. PMID: 24853039, PMCID: PMC4475348, DOI: 10.1016/j.healthplace.2014.04.008.Peer-Reviewed Original Research
2011
Computer-Based Intervention in HIV Clinical Care Setting Improves Antiretroviral Adherence: The LifeWindows Project
Fisher JD, Amico KR, Fisher WA, Cornman DH, Shuper PA, Trayling C, Redding C, Barta W, Lemieux AF, Altice FL, Dieckhaus K, Friedland G, for the LifeWindows Team. Computer-Based Intervention in HIV Clinical Care Setting Improves Antiretroviral Adherence: The LifeWindows Project. AIDS And Behavior 2011, 15: 1635. PMID: 21452051, DOI: 10.1007/s10461-011-9926-x.Peer-Reviewed Original ResearchConceptsHIV clinical care settingsAdherence support interventionsClinical care sitesClinical care settingsHIV careCare visitsAntiretroviral adherenceControl armCare settingsCare sitesProtocol interventionTreat sampleProtocol sampleSupport interventionsComputer-based interventionsIntervention impactControl participantsInterventionAdherenceHIVPatientsCareHigh levelsClinicARV